• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMM 0.00% 33.5¢

IMMUTEP LIMITED - Announcements

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

IMM Change in substantial holding from AEF30/06/21 download Created with Sketch. 179.63KB
IMM Change in substantial holding30/06/21 download Created with Sketch. 905.65KB
IMM Cleansing Notice28/06/21 download Created with Sketch. 233.27KB
IMM Notice of Extraordinary General Meeting/Proxy Form25/06/21 download Created with Sketch. 525.46KB
IMM Share Purchase Plan Offer Documents25/06/21 download Created with Sketch. 1.06MB
IMM Application for quotation of securities - IMM25/06/21 download Created with Sketch. 23.34KB
IMM Efti to be evaluated in new triple combination therapy trialPRICE SENSITIVE21/06/21 download Created with Sketch. 230.43KB
IMM Proposed issue of securities - IMM21/06/21 download Created with Sketch. 25.41KB
IMM Immutep Capital Raising PresentationPRICE SENSITIVE21/06/21 download Created with Sketch. 3.01MB
IMM Immutep secures commitments for A$60 million in a PlacementPRICE SENSITIVE21/06/21 download Created with Sketch. 361.64KB
IMM Trading HaltPRICE SENSITIVE17/06/21 download Created with Sketch. 258.72KB
IMM Change in substantial holding15/06/21 download Created with Sketch. 2.25MB
IMM Immutep global webcast slidesPRICE SENSITIVE09/06/21 download Created with Sketch. 2.53MB
IMM Appendix 2A08/06/21 download Created with Sketch. 66.12KB
IMM Immutep Reveals a New anti-LAG-3 Research ProgramPRICE SENSITIVE08/06/21 download Created with Sketch. 244.44KB
IMM Application for quotation of securities - IMM07/06/21 download Created with Sketch. 24.92KB
IMM Immutep presentation for Jefferies Healthcare Conference04/06/21 download Created with Sketch. 2.25MB
IMM Immutep Reports Positive Data from its TACTI-002 ph 2 trialPRICE SENSITIVE04/06/21 download Created with Sketch. 311.58KB
IMM Immutep Reports Positive Final Data from INSIGHT-004 trialPRICE SENSITIVE04/06/21 download Created with Sketch. 250.79KB
IMM Immutep granted European patent for its LAG-3 candidate EftiPRICE SENSITIVE02/06/21 download Created with Sketch. 228.93KB
IMM Immutep enters New Collaboration with Merck KGaA for EftiPRICE SENSITIVE01/06/21 download Created with Sketch. 234.09KB
IMM Immutep granted Chinese patent for its LAG-3 candidate EftiPRICE SENSITIVE26/05/21 download Created with Sketch. 227.66KB
IMM Immutep to present at Jefferies Healthcare Conference25/05/21 download Created with Sketch. 215.04KB
IMM TACTI-002 and INSIGHT-004 abstracts for ASCO 202120/05/21 download Created with Sketch. 309.91KB
IMM Change in substantial holding20/05/21 download Created with Sketch. 1.88MB
IMM Change in substantial holding18/05/21 download Created with Sketch. 1.9MB
IMM Appendix 2A14/05/21 download Created with Sketch. 285.13KB
IMM Immutep Corporate Presentation13/05/21 download Created with Sketch. 3.42MB
IMM Operational UpdatePRICE SENSITIVE07/05/21 download Created with Sketch. 250.68KB
IMM TACTI-002 & INSIGHT-004 data to be presented at ASCOPRICE SENSITIVE29/04/21 download Created with Sketch. 315.08KB
IMM Immutep Quarterly Activities Report & Appendix 4CPRICE SENSITIVE19/04/21 download Created with Sketch. 570.75KB
IMM Immutep receives A$1,155,055 R&D Tax IncentivePRICE SENSITIVE16/04/21 download Created with Sketch. 211.28KB
IMM Immutep Investor Update14/04/21 download Created with Sketch. 1.83MB
IMM Immutep achieves Fast Track designation for Efti from US FDAPRICE SENSITIVE08/04/21 download Created with Sketch. 251.23KB
IMM Immutep announces European Patent Grant for LAG525PRICE SENSITIVE07/04/21 download Created with Sketch. 230.25KB
IMM Change in substantial holding01/04/21 download Created with Sketch. 1.9MB
IMM Appendix 2A18/03/21 download Created with Sketch. 235.94KB
IMM Immutep collaborates with MSD for phase 2b head & neck trialPRICE SENSITIVE16/03/21 download Created with Sketch. 274.62KB
IMM S&P DJI Announces March 2021 Quarterly RebalancePRICE SENSITIVE12/03/21 download Created with Sketch. 183.24KB
IMM Immutep secures second US patent grant for eftilagimod alphaPRICE SENSITIVE09/03/21 download Created with Sketch. 231.9KB
IMM Immutep expands Part B of TACTI-002 collaboration trialPRICE SENSITIVE05/03/21 download Created with Sketch. 293.47KB
IMM Half Yearly Report and AccountsPRICE SENSITIVE23/02/21 download Created with Sketch. 594.81KB
IMM Immutep Corporate Presentation02/02/21 download Created with Sketch. 2.31MB
IMM Phase II study for eftilagimod alpha in COVID-19 advancesPRICE SENSITIVE27/01/21 download Created with Sketch. 253.86KB
IMM Immutep Quarterly Activities Report & Appendix 4CPRICE SENSITIVE22/01/21 download Created with Sketch. 504.63KB
IMM Ulcerative Colitis Phase II Study of GSK2831781 DiscontinuedPRICE SENSITIVE22/01/21 download Created with Sketch. 277.31KB
IMM Recruitment of head & neck cancer patients completed for ph2PRICE SENSITIVE07/01/21 download Created with Sketch. 226.01KB
IMM Resignation and Appointment of Joint Company Secretary04/01/21 download Created with Sketch. 228.09KB
IMM Change in substantial holding04/01/21 download Created with Sketch. 193.79KB
IMM Appendix 2A31/12/20 download Created with Sketch. 285.8KB
IMM Change in substantial holding31/12/20 download Created with Sketch. 1.9MB
IMM Change in substantial holding30/12/20 download Created with Sketch. 1.64MB
IMM Immutep granted US patent for eftilagimod alpha with a PD-1PRICE SENSITIVE30/12/20 download Created with Sketch. 235.36KB
IMM Change in substantial holding29/12/20 download Created with Sketch. 1.64MB
IMM Change of Director's Interest Notice - Dr Howard24/12/20 download Created with Sketch. 154.34KB
IMM Appendix 2A24/12/20 download Created with Sketch. 237.49KB
IMM Becoming a substantial holder24/12/20 download Created with Sketch. 1.58MB
IMM Change in substantial holding18/12/20 download Created with Sketch. 1.9MB
IMM Change in substantial holding17/12/20 download Created with Sketch. 1.07MB
IMM Immutep Upscales Efti ManufacturingPRICE SENSITIVE16/12/20 download Created with Sketch. 271.36KB
IMM Change in substantial holding16/12/20 download Created with Sketch. 1.89MB
IMM Operational UpdatePRICE SENSITIVE15/12/20 download Created with Sketch. 255.39KB
IMM Ceasing to be a substantial holder15/12/20 download Created with Sketch. 396.12KB
IMM Change in substantial holding15/12/20 download Created with Sketch. 1.9MB
IMM Appendix 2A11/12/20 download Created with Sketch. 285.65KB
IMM Webcast slides for AIPAC Phase IIb breast cancer trial11/12/20 download Created with Sketch. 2.02MB
IMM Immutep's partner EOC pharma to start Ph II trial in MBCPRICE SENSITIVE10/12/20 download Created with Sketch. 280.1KB
IMM Overall Survival data from ph IIb AIPAC breast cancer trialPRICE SENSITIVE10/12/20 download Created with Sketch. 394.58KB
IMM Change in substantial holding from AEF27/11/20 download Created with Sketch. 212.98KB
IMM Change in substantial holding27/11/20 download Created with Sketch. 1.07MB
IMM Cleansing Notice25/11/20 download Created with Sketch. 190.74KB
IMM Change of substantial holding from AEF24/11/20 download Created with Sketch. 190.66KB
IMM Appendix 2A24/11/20 download Created with Sketch. 281.34KB
IMM Proposed issue of Securities - IMMPRICE SENSITIVE19/11/20 download Created with Sketch. 25.35KB
IMM Immutep Investor Presentation19/11/20 download Created with Sketch. 2.26MB
IMM Immutep completes a A$29.6 million placementPRICE SENSITIVE19/11/20 download Created with Sketch. 283.79KB
IMM Immutep expands TACTI-002 Collaboration Trial with MSDPRICE SENSITIVE19/11/20 download Created with Sketch. 242.02KB
IMM Change in substantial holding18/11/20 download Created with Sketch. 1.9MB
IMM Trading HaltPRICE SENSITIVE17/11/20 download Created with Sketch. 280.45KB
IMM Pause in TradingPRICE SENSITIVE17/11/20 download Created with Sketch. 114.67KB
IMM Encouraging Phase II TACTI-002 data reported at SITC 2020PRICE SENSITIVE10/11/20 download Created with Sketch. 366.98KB
IMM Immutep Announces Australian Patent Grant for IMP701PRICE SENSITIVE09/11/20 download Created with Sketch. 206.9KB
IMM Change of Director's Interest Notice - Grant Chamberlain06/11/20 download Created with Sketch. 294.56KB
IMM Appendix 3G06/11/20 download Created with Sketch. 292.87KB
IMM Proposed issue of Securities - IMM06/11/20 download Created with Sketch. 25.03KB
IMM Immutep to present TACTI-002 phase 2 data at SITC 202003/11/20 download Created with Sketch. 285.33KB
IMM Lapse of Unlisted Options02/11/20 download Created with Sketch. 243.77KB
IMM Immutep enters into a Licence & Collaboration with LabCorpPRICE SENSITIVE30/10/20 download Created with Sketch. 233.43KB
IMM Results of Meeting27/10/20 download Created with Sketch. 282.66KB
IMM Chairman's AGM Address27/10/20 download Created with Sketch. 206.53KB
IMM 2020 AGM PresentationPRICE SENSITIVE27/10/20 download Created with Sketch. 1.11MB
IMM COVID-19 phase 2 investigator initiated trial commencesPRICE SENSITIVE23/10/20 download Created with Sketch. 287.87KB
IMM Immutep Quarterly Activities Report & Appendix 4CPRICE SENSITIVE22/10/20 download Created with Sketch. 489.39KB
IMM Immutep granted European patent for IMP761PRICE SENSITIVE21/10/20 download Created with Sketch. 224.06KB
IMM Immutep to present AIPAC Overall Survival data at SABCS 202019/10/20 download Created with Sketch. 287.17KB
IMM Change in substantial holding06/10/20 download Created with Sketch. 1.08MB
IMM Change of Director's Interest Notice - Mr Chamberlain05/10/20 download Created with Sketch. 196.59KB
IMM Change of Director's Interest Notice - Mr Meyers05/10/20 download Created with Sketch. 204.34KB
IMM Change of Director's Interest Notice - Mr Voigt05/10/20 download Created with Sketch. 191.84KB
IMM Appendix 2A02/10/20 download Created with Sketch. 290.32KB
IMM Change in substantial holding from AEF
30/06/21 download Created with Sketch. 179.63KB
IMM Change in substantial holding
30/06/21 download Created with Sketch. 905.65KB
IMM Cleansing Notice
28/06/21 download Created with Sketch. 233.27KB
IMM Notice of Extraordinary General Meeting/Proxy Form
25/06/21 download Created with Sketch. 525.46KB
IMM Share Purchase Plan Offer Documents
25/06/21 download Created with Sketch. 1.06MB
IMM Application for quotation of securities - IMM
25/06/21 download Created with Sketch. 23.34KB
IMM Efti to be evaluated in new triple combination therapy trial
21/06/21PRICE SENSITIVE download Created with Sketch. 230.43KB
IMM Proposed issue of securities - IMM
21/06/21 download Created with Sketch. 25.41KB
IMM Immutep Capital Raising Presentation
21/06/21PRICE SENSITIVE download Created with Sketch. 3.01MB
IMM Immutep secures commitments for A$60 million in a Placement
21/06/21PRICE SENSITIVE download Created with Sketch. 361.64KB
IMM Trading Halt
17/06/21PRICE SENSITIVE download Created with Sketch. 258.72KB
IMM Change in substantial holding
15/06/21 download Created with Sketch. 2.25MB
IMM Immutep global webcast slides
09/06/21PRICE SENSITIVE download Created with Sketch. 2.53MB
IMM Appendix 2A
08/06/21 download Created with Sketch. 66.12KB
IMM Immutep Reveals a New anti-LAG-3 Research Program
08/06/21PRICE SENSITIVE download Created with Sketch. 244.44KB
IMM Application for quotation of securities - IMM
07/06/21 download Created with Sketch. 24.92KB
IMM Immutep presentation for Jefferies Healthcare Conference
04/06/21 download Created with Sketch. 2.25MB
IMM Immutep Reports Positive Data from its TACTI-002 ph 2 trial
04/06/21PRICE SENSITIVE download Created with Sketch. 311.58KB
IMM Immutep Reports Positive Final Data from INSIGHT-004 trial
04/06/21PRICE SENSITIVE download Created with Sketch. 250.79KB
IMM Immutep granted European patent for its LAG-3 candidate Efti
02/06/21PRICE SENSITIVE download Created with Sketch. 228.93KB
IMM Immutep enters New Collaboration with Merck KGaA for Efti
01/06/21PRICE SENSITIVE download Created with Sketch. 234.09KB
IMM Immutep granted Chinese patent for its LAG-3 candidate Efti
26/05/21PRICE SENSITIVE download Created with Sketch. 227.66KB
IMM Immutep to present at Jefferies Healthcare Conference
25/05/21 download Created with Sketch. 215.04KB
IMM TACTI-002 and INSIGHT-004 abstracts for ASCO 2021
20/05/21 download Created with Sketch. 309.91KB
IMM Change in substantial holding
20/05/21 download Created with Sketch. 1.88MB
IMM Change in substantial holding
18/05/21 download Created with Sketch. 1.9MB
IMM Appendix 2A
14/05/21 download Created with Sketch. 285.13KB
IMM Immutep Corporate Presentation
13/05/21 download Created with Sketch. 3.42MB
IMM Operational Update
07/05/21PRICE SENSITIVE download Created with Sketch. 250.68KB
IMM TACTI-002 & INSIGHT-004 data to be presented at ASCO
29/04/21PRICE SENSITIVE download Created with Sketch. 315.08KB
IMM Immutep Quarterly Activities Report & Appendix 4C
19/04/21PRICE SENSITIVE download Created with Sketch. 570.75KB
IMM Immutep receives A$1,155,055 R&D Tax Incentive
16/04/21PRICE SENSITIVE download Created with Sketch. 211.28KB
IMM Immutep Investor Update
14/04/21 download Created with Sketch. 1.83MB
IMM Immutep achieves Fast Track designation for Efti from US FDA
08/04/21PRICE SENSITIVE download Created with Sketch. 251.23KB
IMM Immutep announces European Patent Grant for LAG525
07/04/21PRICE SENSITIVE download Created with Sketch. 230.25KB
IMM Change in substantial holding
01/04/21 download Created with Sketch. 1.9MB
IMM Appendix 2A
18/03/21 download Created with Sketch. 235.94KB
IMM Immutep collaborates with MSD for phase 2b head & neck trial
16/03/21PRICE SENSITIVE download Created with Sketch. 274.62KB
IMM S&P DJI Announces March 2021 Quarterly Rebalance
12/03/21PRICE SENSITIVE download Created with Sketch. 183.24KB
IMM Immutep secures second US patent grant for eftilagimod alpha
09/03/21PRICE SENSITIVE download Created with Sketch. 231.9KB
IMM Immutep expands Part B of TACTI-002 collaboration trial
05/03/21PRICE SENSITIVE download Created with Sketch. 293.47KB
IMM Half Yearly Report and Accounts
23/02/21PRICE SENSITIVE download Created with Sketch. 594.81KB
IMM Immutep Corporate Presentation
02/02/21 download Created with Sketch. 2.31MB
IMM Phase II study for eftilagimod alpha in COVID-19 advances
27/01/21PRICE SENSITIVE download Created with Sketch. 253.86KB
IMM Immutep Quarterly Activities Report & Appendix 4C
22/01/21PRICE SENSITIVE download Created with Sketch. 504.63KB
IMM Ulcerative Colitis Phase II Study of GSK2831781 Discontinued
22/01/21PRICE SENSITIVE download Created with Sketch. 277.31KB
IMM Recruitment of head & neck cancer patients completed for ph2
07/01/21PRICE SENSITIVE download Created with Sketch. 226.01KB
IMM Resignation and Appointment of Joint Company Secretary
04/01/21 download Created with Sketch. 228.09KB
IMM Change in substantial holding
04/01/21 download Created with Sketch. 193.79KB
IMM Appendix 2A
31/12/20 download Created with Sketch. 285.8KB
IMM Change in substantial holding
31/12/20 download Created with Sketch. 1.9MB
IMM Change in substantial holding
30/12/20 download Created with Sketch. 1.64MB
IMM Immutep granted US patent for eftilagimod alpha with a PD-1
30/12/20PRICE SENSITIVE download Created with Sketch. 235.36KB
IMM Change in substantial holding
29/12/20 download Created with Sketch. 1.64MB
IMM Change of Director's Interest Notice - Dr Howard
24/12/20 download Created with Sketch. 154.34KB
IMM Appendix 2A
24/12/20 download Created with Sketch. 237.49KB
IMM Becoming a substantial holder
24/12/20 download Created with Sketch. 1.58MB
IMM Change in substantial holding
18/12/20 download Created with Sketch. 1.9MB
IMM Change in substantial holding
17/12/20 download Created with Sketch. 1.07MB
IMM Immutep Upscales Efti Manufacturing
16/12/20PRICE SENSITIVE download Created with Sketch. 271.36KB
IMM Change in substantial holding
16/12/20 download Created with Sketch. 1.89MB
IMM Operational Update
15/12/20PRICE SENSITIVE download Created with Sketch. 255.39KB
IMM Ceasing to be a substantial holder
15/12/20 download Created with Sketch. 396.12KB
IMM Change in substantial holding
15/12/20 download Created with Sketch. 1.9MB
IMM Appendix 2A
11/12/20 download Created with Sketch. 285.65KB
IMM Webcast slides for AIPAC Phase IIb breast cancer trial
11/12/20 download Created with Sketch. 2.02MB
IMM Immutep's partner EOC pharma to start Ph II trial in MBC
10/12/20PRICE SENSITIVE download Created with Sketch. 280.1KB
IMM Overall Survival data from ph IIb AIPAC breast cancer trial
10/12/20PRICE SENSITIVE download Created with Sketch. 394.58KB
IMM Change in substantial holding from AEF
27/11/20 download Created with Sketch. 212.98KB
IMM Change in substantial holding
27/11/20 download Created with Sketch. 1.07MB
IMM Cleansing Notice
25/11/20 download Created with Sketch. 190.74KB
IMM Change of substantial holding from AEF
24/11/20 download Created with Sketch. 190.66KB
IMM Appendix 2A
24/11/20 download Created with Sketch. 281.34KB
IMM Proposed issue of Securities - IMM
19/11/20PRICE SENSITIVE download Created with Sketch. 25.35KB
IMM Immutep Investor Presentation
19/11/20 download Created with Sketch. 2.26MB
IMM Immutep completes a A$29.6 million placement
19/11/20PRICE SENSITIVE download Created with Sketch. 283.79KB
IMM Immutep expands TACTI-002 Collaboration Trial with MSD
19/11/20PRICE SENSITIVE download Created with Sketch. 242.02KB
IMM Change in substantial holding
18/11/20 download Created with Sketch. 1.9MB
IMM Trading Halt
17/11/20PRICE SENSITIVE download Created with Sketch. 280.45KB
IMM Pause in Trading
17/11/20PRICE SENSITIVE download Created with Sketch. 114.67KB
IMM Encouraging Phase II TACTI-002 data reported at SITC 2020
10/11/20PRICE SENSITIVE download Created with Sketch. 366.98KB
IMM Immutep Announces Australian Patent Grant for IMP701
09/11/20PRICE SENSITIVE download Created with Sketch. 206.9KB
IMM Change of Director's Interest Notice - Grant Chamberlain
06/11/20 download Created with Sketch. 294.56KB
IMM Appendix 3G
06/11/20 download Created with Sketch. 292.87KB
IMM Proposed issue of Securities - IMM
06/11/20 download Created with Sketch. 25.03KB
IMM Immutep to present TACTI-002 phase 2 data at SITC 2020
03/11/20 download Created with Sketch. 285.33KB
IMM Lapse of Unlisted Options
02/11/20 download Created with Sketch. 243.77KB
IMM Immutep enters into a Licence & Collaboration with LabCorp
30/10/20PRICE SENSITIVE download Created with Sketch. 233.43KB
IMM Results of Meeting
27/10/20 download Created with Sketch. 282.66KB
IMM Chairman's AGM Address
27/10/20 download Created with Sketch. 206.53KB
IMM 2020 AGM Presentation
27/10/20PRICE SENSITIVE download Created with Sketch. 1.11MB
IMM COVID-19 phase 2 investigator initiated trial commences
23/10/20PRICE SENSITIVE download Created with Sketch. 287.87KB
IMM Immutep Quarterly Activities Report & Appendix 4C
22/10/20PRICE SENSITIVE download Created with Sketch. 489.39KB
IMM Immutep granted European patent for IMP761
21/10/20PRICE SENSITIVE download Created with Sketch. 224.06KB
IMM Immutep to present AIPAC Overall Survival data at SABCS 2020
19/10/20 download Created with Sketch. 287.17KB
IMM Change in substantial holding
06/10/20 download Created with Sketch. 1.08MB
IMM Change of Director's Interest Notice - Mr Chamberlain
05/10/20 download Created with Sketch. 196.59KB
IMM Change of Director's Interest Notice - Mr Meyers
05/10/20 download Created with Sketch. 204.34KB
IMM Change of Director's Interest Notice - Mr Voigt
05/10/20 download Created with Sketch. 191.84KB
IMM Appendix 2A
02/10/20 download Created with Sketch. 290.32KB
(20min delay)
Last
33.5¢
Change
0.000(0.00%)
Mkt cap ! $486.6M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 4587 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 36781 4
View Market Depth
Last trade - 09.51am 02/10/2024 (20 minute delay) ?
Last
32.5¢
  Change
0.000 ( 1.60 %)
Open High Low Volume
32.5¢ 32.5¢ 32.5¢ 109833
Last updated 10.08am 02/10/2024 ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.